Human Immunodeficiency Virus (HIV) Clinical Trial
Official title:
Young Women-Focused HIV Prevention: Seek & Test in North Carolina (NC) Clinics
Verified date | November 2023 |
Source | RTI International |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This three-arm cross-over randomized trial will develop, test, and compare the efficacy of two delivery formats of the Young Women's CoOp (YWC), which is designed to provide risk reduction and empowerment skills, as well as linkages to healthcare services for women who use substances. The current study will develop a revised version of the YWC and evaluate the relative efficacy of a face-to-face (face-to-face YWC), mobile Health application (mHealth YWC) delivery format, and HIV counseling and testing (HCT) as a control to reduce risky sexual behaviors and reduce substance use among young (18-25) African American women who use substances and are sexually active and have not recently been tested for HIV in three NC counties.
Status | Terminated |
Enrollment | 652 |
Est. completion date | March 17, 2020 |
Est. primary completion date | March 17, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 25 Years |
Eligibility | Selected Inclusion Criteria: - Identify as female - Identify as Black or African American - 18-25 years of age - Have used alcohol or drugs in greater quantity or for a longer period of time than intended within the past 30 days Exclusion Criteria: - Participants may not be non-Black/African American |
Country | Name | City | State |
---|---|---|---|
United States | Durham County Department of Public Health | Durham | North Carolina |
United States | Guilford County Department of Public Health - Greensboro | Greensboro | North Carolina |
United States | Guilford County Department of Public Health - High Point | High Point | North Carolina |
United States | Wake County Human Services | Raleigh | North Carolina |
Lead Sponsor | Collaborator |
---|---|
RTI International | Durham County Department of Public Health, Guilford County Department of Public Health, Wake County Human Services |
United States,
Browne FA, Washio Y, Zule WA, Wechsberg WM. HIV-related risk among justice-involved young African American women in the U.S. South. Health Justice. 2023 Aug 24;11(1):32. doi: 10.1186/s40352-023-00228-7. — View Citation
Osakwe CE, van der Drift I, Opper CA, Zule WA, Browne FA, Wechsberg WM. Condom Use at Last Sex and Sexual Negotiation Among Young African American Women in North Carolina: Context or Personal Agency. J Racial Ethn Health Disparities. 2023 Jul 26. doi: 10. — View Citation
Watkins RL, Browne FA, Kizakevich PN, Howard BN, Turner LB, Eckhoff R, Wechsberg WM. An Evidence-Based HIV Risk-Reduction Intervention for Young African American Women in the US South Using mHealth: Adaptation and Development Study. JMIR Form Res. 2022 Ma — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Condomless Sex | Self-reported frequency of condomless sex | Baseline | |
Primary | Condomless Sex | Self-reported frequency of condomless sex | 6-month follow-up | |
Primary | Condomless Sex | Self-reported frequency of condomless sex | 12-month follow-up | |
Primary | Frequency of Substance Use | Frequency of using illicit drugs and alcohol | Baseline | |
Primary | Frequency of Substance Use | Frequency of using illicit drugs and alcohol | 6-month follow-up | |
Primary | Frequency of Substance Use | Frequency of using illicit drugs and alcohol | 12-month follow-up | |
Secondary | Increased Sexual Negotiation | Self-reported ability to negotiate condom use and other safe sexual behavior with a male partner | Baseline | |
Secondary | Increased Sexual Negotiation | Self-reported ability to negotiate condom use and other safe sexual behavior with a male partner | 6-month follow-up | |
Secondary | Increased Sexual Negotiation | Self-reported ability to negotiate condom use and other safe sexual behavior with a male partner | 12-month follow-up | |
Secondary | Reduced Alcohol and Illicit Drug Use for a Subsample of Participants | Self-reported amount of alcohol consumption and drugs used; Urine drug screen will be used to test for recent illicit drug use; Breathalyzer test results will be used to assess recent alcohol use | Baseline | |
Secondary | Reduced Alcohol and Illicit Drug Use for a Subsample of Participants | Self-reported amount of alcohol consumption and drugs used; Urine drug screen will be used to test for recent illicit drug use; Breathalyzer test results will be used to assess recent alcohol use | 6-month follow-up | |
Secondary | Reduced Alcohol and Illicit Drug Use for a Subsample of Participants | Self-reported amount of alcohol consumption and drugs used; Urine drug screen will be used to test for recent illicit drug use; Breathalyzer test results will be used to assess recent alcohol use | 12-month follow-up | |
Secondary | Reduced Violence and Victimization for a Subsample of Participants | Self-reported experiences of emotional, physical, and sexual abuse | Baseline | |
Secondary | Reduced Violence and Victimization for a Subsample of Participants | Self-reported experiences of emotional, physical, and sexual abuse | 6-month follow-up | |
Secondary | Reduced Violence and Victimization for a Subsample of Participants | Self-reported experiences of emotional, physical, and sexual abuse | 12-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02511496 -
Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia
|
N/A | |
Completed |
NCT02234492 -
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
|
Phase 4 | |
Completed |
NCT01685372 -
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
|
Phase 2 | |
Completed |
NCT02027441 -
Enhanced Prevention in Couples: Feasibility Study #2
|
N/A | |
Completed |
NCT02165202 -
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
|
Phase 2 | |
Completed |
NCT02572401 -
Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men
|
N/A | |
Completed |
NCT01449006 -
A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
|
Phase 4 | |
Terminated |
NCT01448486 -
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
|
Phase 4 | |
Completed |
NCT01615601 -
An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients
|
Phase 4 | |
Completed |
NCT04122404 -
POC Strategies to Improve TB Care in Advanced HIV Disease
|
N/A | |
Completed |
NCT03290755 -
Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux
|
||
Completed |
NCT02974998 -
Cape Town Young Women's Health CoOp
|
N/A | |
Completed |
NCT01997346 -
Multi-level Determinants of Starting ART Late: Aim 2
|
N/A | |
Completed |
NCT01516970 -
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
|
Phase 3 | |
Active, not recruiting |
NCT01875952 -
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
|
Phase 4 | |
Completed |
NCT01199939 -
A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
|
Phase 2 | |
Completed |
NCT03783130 -
Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults
|
Phase 1 | |
Active, not recruiting |
NCT05657106 -
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
|
N/A | |
Not yet recruiting |
NCT05727033 -
Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections
|
N/A | |
Completed |
NCT01053741 -
Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission
|
N/A |